INV, CA46136U1030

Invesque stock heads toward a go private vote after 68% offer

Published on 10/07/2026 at 05:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Invesque stock faces a US$0.101 cash offer announced October 1, 2026. The planned shareholder vote is expected by November 20, with closing targeted before year-end.

INV, CA46136U1030, Illustration mit AI erstellt.
INV, CA46136U1030, Illustration mit AI erstellt.

Invesque stock is tied to a US$0.101 cash offer after the healthcare real estate company agreed on October 1, 2026, to a go-private transaction led by controlling shareholder Magnetar Financial. The consideration equals CAD 0.143 based on the Bank of Canada exchange rate cited for September 29, 2026, and would take the company off the TSX if approved. Invesque said the arrangement was approved unanimously by its board, with interested directors abstaining.

Offer sets a clear value

The offer represents a 68% premium to the spot price and a 30% premium to the volume-weighted average trading price for the 20 trading days ended September 29, 2026, according to Invesque. The premium is the central investor issue because the company has been selling assets and retiring debt while reducing the operating platform available to public shareholders.

Invesque currently has four senior housing properties and a portfolio of loans receivable, the company said in the October 1 release. Three of those four properties are subject to purchase and sale agreements with targeted closing dates before December 31, 2026, although each transaction remains subject to due diligence and closing conditions.

Vote remains the next checkpoint

The arrangement requires approval from the Supreme Court of British Columbia and shareholders under the voting thresholds described in the company release. Invesque expects the special meeting to take place on or before November 20, 2026, while the transaction is targeted to close by the end of 2026 and, unless extended, before January 31, 2027.

Magnetar funds controlled 731,433,131 shares, representing 80.1% of Invesque's issued and outstanding shares when the agreement was signed. That ownership position gives the controlling shareholder substantial influence over the vote, while the formal arrangement still includes approval conditions and a fairness opinion prepared for the special committee.

Stock stays below offer value

Invesque stock was last quoted at CAD 0.135 on the TSX on October 2, 2026. The quote page showed a 52-week range of CAD 0.090 to CAD 0.170, a market capitalization of CAD 123.3 million and volume of 96,160 shares for that session.

Invesque stock at a glance

  • Company: Invesque Inc.
  • ISIN: CA46136U1030
  • Ticker: IVQ
  • Trading venue: TSX
  • Price (as of October 2, 2026): CAD 0.135
  • Market capitalization: CAD 123.3 million (as of October 2, 2026)
  • 52-week range: CAD 0.090-0.170 (as of October 2, 2026)
  • Sector / Industry: Health care real estate

Upcoming dates for Invesque stock

  • November 20, 2026: Shareholder meeting deadline
  • December 31, 2026: Targeted transaction closing period

More news and analyses on Invesque stock

Disclaimer...

en | CA46136U1030 | INV | boerse | 70249495 | bgmi